Leukemia Tissue Bank
Leukemia Tissue Bank
批准号:
7630214
负责人:
Sherif S Farag
金额:
$5.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AcuteAppointmentArtsAspirate substanceBasic ScienceBiologicalBloodBlood Component RemovalBlood specimenBone MarrowCancer and Leukemia Group BCentrifugationClinicalClinical DataClinical PathologyClinical ResearchClinical TrialsCollaborationsCollectionCommitConfidentialityConsentCountryCytogeneticsDNADataDatabasesDiagnosisDiagnosticDiseaseDoctor of MedicineDoctor of PhilosophyDrug KineticsEastern Cooperative Oncology GroupFreezingFundingGerm LinesGoalsGrowthHematologic NeoplasmsHematologistHeterogeneityHuman ResourcesInformed ConsentInstitutionLaboratoriesLeadershipLeftLymphomaMalignant NeoplasmsMedical OncologistMissionMolecularMolecular AnalysisMolecular CytogeneticsNatural HistoryNormal tissue morphologyNumbersOncology GroupOperative Surgical ProceduresOutcomePathologicPathologistPatientsPersonal SatisfactionPlasmaPlayPoliciesProceduresProcessPropertyProtocols documentationPublicationsQuality ControlRegulationResearchResearch Ethics CommitteesResearch InfrastructureResearch PersonnelResource SharingResourcesRetrievalRoleRoswell Park Cancer InstituteSamplingShippingShipsSolidSolid NeoplasmSourceSouthwest Oncology GroupSpecimenStandards of Weights and MeasuresSupport of ResearchSurgeonSwabThe Comprehensive Cancer Center Arthur G James Cancer Hospital and Richard J Solove Research Institute at Ohio State UniversityTimeTissue BanksTissue ProcurementsTissue SampleTissuesTrainingTranslatingTranslationsTumor BankWeekWorkloadbasechronic leukemiadaydensityexperiencefollow-upinterestleukemialeukemia/lymphomamemberoutcome forecastradiologistrepositoryresponsesample collectionstemsuccesstherapeutic targettissue resource
中文摘要
成功地将白血病基础研究转化为临床环境的能力,以及更好地
通过实验室研究了解观察到的临床现象的相关性,
通过提供广泛的组织样本库,以及随附的完整的
从白血病患者中获得的病理和临床数据。OSUCCC白血病组织库
共享资源(LTBSR),独立于CALGB白血病组织库,是一个共享的
1997年建立的资源,从762例同意的白血病患者中采购了4,500多份患者样本
患者在OSU OSUCCC LTBSR的基础设施完善,直接隶属于我们的
领导具体来说,我们有一个大型的白血病组织库,包括白血病组织和
所有病例均伴有完整的病理、细胞遗传学和临床表现,
数据用于临床和生物学结果的快速关联。此外,有效治疗白血病的所有要素
组织库管理,包括组织采集、标本质量控制、组织
初始和随访样本及其病理学和临床信息的储存、获取、数据录入
和数据库管理,以及患者同意和保密性都得到了很好的发展。此外,委员会认为,
OUCCC内对大量研究者进行组织优先排序和分配的程序如下
有效到位。最后,我们在管理这种大型白血病组织资源方面的成功可以从以下方面看到:
记录CCC内所有白血病研究人员的样本采集和样本分发,
OSUCCC LTBSR发挥了重要作用的出版物。在此背景下,我们认为
这一共享资源将在支持OSUCCC的研究使命方面发挥良好作用,
)开展高质量的恶性血液病基础和临床研究。目前,OSUCCC
_坦桑尼亚联合共和国完全由坦桑尼亚联合共和国儿童基金会/机构支助供资。本共享资源的具体目标是,
1)继续提供中央收集、处理和最先进的储存库,
从接受OSU方案治疗的白血病患者中收集的样本,以及2)提供来自
向OSUCCC内部的相关研究者以及参与以下研究的外部相关研究者提供LTBSR
与俄勒冈州立大学的合作研究,他们检查白血病的相关细胞和分子特性。
英文摘要
The ability to successfully translate basic research in leukemia to the clinical setting, as well as to better
understand the relevance of observed clinical phenomena through laboratory-based research, is greatly
facilitated by the availability of an extensive repository of tissue samples, with accompanying complete
pathologic and clinical data, procured from leukemia patients. The OSUCCC Leukemia Tissue Bank
Shared Resource (LTBSR), separate and distinct from the CALGB Leukemia Tissue Bank, is a shared
resource established in 1997 with over 4,500 patient samples procured from 762 consented leukemia
patients at OSU. The infrastructure of the OSUCCC LTBSR is well-established and is directly under our
leadership. Specifically we have a large leukemia tissue repository, including both leukemic tissue and
normal tissue germ line DNA, accompanied in all cases with complete pathologic, cytogenetic and clinical
data for ready correlation of clinical and biological results. In addition, all the essentials of effective leukemia
tissue bank management, including the activities of tissue collection, quality control of specimens, tissue
storage, procurement of initial and follow-up samples and their pathology and clinical information, data entry
and database management, and patient consent and confidentiality are very well developed. Furthermore,
the procedures for prioritizing and distributing tissue to a large base of investigators within the OUCCC are
effectively in place. Finally, our success in managing this large leukemia tissue resource can be seen in the
documented sample collection for and sample distribution to all leukemia researchers within the CCC and 28
publications where the OSUCCC LTBSR has played a significant role. Against this background, we believe
that this Shared Resource will function well in the support of the research mission of the OSUCCC in
)roducing high-quality basic and clinical research in hematological malignancy. Currently the OSUCCC
_TBSR is funded solely with OSUCCC/institutional support. The Specific Aims of this Shared Resource are,
therefore, to: 1) Continue to provide a central collection, processing and a state-of-the-art repository for
samples collected from leukemia patients treated on OSU protocols, and 2) Provide materials from the
LTBSR to interested investigators within OSUCCC, as well as to outside interested investigators involved in
collaborative studies with OSU, who examine relevant cellular and molecular properties of leukemia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells
-
批准号:9261489
-
项目类别:
-
资助金额:$32.19万
-
财政年份:2014
-
负责人:Sherif S Farag
-
依托单位:
Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells
-
批准号:8633799
-
项目类别:
-
资助金额:$34.95万
-
财政年份:2014
-
负责人:Sherif S Farag
-
依托单位:
Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells
-
批准号:9052158
-
项目类别:
-
资助金额:$32.19万
-
财政年份:2014
-
负责人:Sherif S Farag
-
依托单位:
Multiple kinase target inhibition with EMND-2076 in multiple myeloma
-
批准号:8013948
-
项目类别:
-
资助金额:$31.0万
-
财政年份:2010
-
负责人:Sherif S Farag
-
依托单位:
Multiple kinase target inhibition with EMND-2076 in multiple myeloma
-
批准号:7787139
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2010
-
负责人:Sherif S Farag
-
依托单位:
Pathology
-
批准号:6986013
-
项目类别:
-
资助金额:$20.85万
-
财政年份:2005
-
负责人:Sherif S Farag
-
依托单位:
Leukemia Tissue Bank
-
批准号:7613092
-
项目类别:
-
资助金额:$3.38万
-
财政年份:2005
-
负责人:Sherif S Farag
-
依托单位:
QMS Technology to Deplete T Cell Alloreactivity
-
批准号:6891062
-
项目类别:
-
资助金额:$59.94万
-
财政年份:2004
-
负责人:Sherif S Farag
-
依托单位:
mTOR Inhibition as a Therapeutic Target in Myeloma
-
批准号:6940691
-
项目类别:
-
资助金额:$26.91万
-
财政年份:2004
-
负责人:Sherif S Farag
-
依托单位:
mTOR Inhibition as a Therapeutic Target in Myeloma
-
批准号:6887130
-
项目类别:
-
资助金额:$26.91万
-
财政年份:2004
-
负责人:Sherif S Farag
-
依托单位:
QMS Technology to Deplete T Cell Alloreactivity
-
批准号:7460784
-
项目类别:
-
资助金额:$58.86万
-
财政年份:2004
-
负责人:Sherif S Farag
-
依托单位:
QMS Technology to Deplete T Cell Alloreactivity
-
批准号:7242522
-
项目类别:
-
资助金额:$60.97万
-
财政年份:2004
-
负责人:Sherif S Farag
-
依托单位:
QMS Technology to Deplete T Cell Alloreactivity
-
批准号:6778639
-
项目类别:
-
资助金额:$58.74万
-
财政年份:2004
-
负责人:Sherif S Farag
-
依托单位:
QMS Technology to Deplete T Cell Alloreactivity
-
批准号:7352036
-
项目类别:
-
资助金额:$59.58万
-
财政年份:2004
-
负责人:Sherif S Farag
-
依托单位:
NK Cell Recognition of Leukemia Blasts and IL-2 Therapy
-
批准号:6801432
-
项目类别:
-
资助金额:$26.61万
-
财政年份:2003
-
负责人:Sherif S Farag
-
依托单位:
NK Cell Recognition of Leukemia Blasts and IL-2 Therapy
-
批准号:6741595
-
项目类别:
-
资助金额:$26.61万
-
财政年份:2003
-
负责人:Sherif S Farag
-
依托单位:
Innate Immune Cell Therapy with Stem Cell Transplants
-
批准号:6653905
-
项目类别:
-
资助金额:$32.82万
-
财政年份:2002
-
负责人:Sherif S Farag
-
依托单位:
Innate Immune Cell Therapy with Stem Cell Transplants
-
批准号:6584712
-
项目类别:
-
资助金额:$32.82万
-
财政年份:2002
-
负责人:Sherif S Farag
-
依托单位:
Leukemia Tissue Bank
-
批准号:7630234
-
项目类别:
-
资助金额:$6.64万
-
财政年份:--
-
负责人:Sherif S Farag
-
依托单位:
Pathology
-
批准号:7901428
-
项目类别:
-
资助金额:$33.14万
-
财政年份:--
-
负责人:Sherif S Farag
-
依托单位:
海外基金